The trial tested multiple dose levels over 48 weeks, and the headline result, up to 24.2% body weight reduction at the highest dose, grabbed international attention
The most significant published evidence to date comes from a phase 2 randomised controlled trial (Jastreboff et al., New England Journal of Medicine , 2023), which demonstrated substantial dose-dependent weight loss in adults with obesity over 24 weeks, with continued weight reduction observed at 48 weeks
How should I store my Retatrutide once its reconstituted
B-Complex Injections are a popular choice for general nutrition supplementation due to anti-inflammatory and antioxidant properties
These compounds influence various functions such as mood, cognition, memory, learning, and motor activity